Your browser doesn't support javascript.
loading
IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.
Leca, Julie; Lemonnier, FranÒ«ois; Meydan, Cem; Foox, Jonathan; El Ghamrasni, Samah; Mboumba, Diana-Laure; Duncan, Gordon S; Fortin, Jerome; Sakamoto, Takashi; Tobin, Chantal; Hodgson, Kelsey; Haight, Jillian; Smith, Logan K; Elia, Andrew J; Butler, Daniel; Berger, Thorsten; de Leval, Laurence; Mason, Christopher E; Melnick, Ari; Gaulard, Philippe; Mak, Tak W.
Afiliação
  • Leca J; University Health Network, Princess Margaret Cancer Centre, Toronto, ON M5G 1L7, Canada. Electronic address: julie.leca@uhnresearch.ca.
  • Lemonnier F; University Paris-Est Créteil, INSERM U955, Institut Mondor de Recherche Biomédicale, 94010 Créteil, France; AP-HP, Lymphoid Malignancies Unit, Henri Mondor Hospital, 94010 Créteil, France.
  • Meydan C; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY 10021, USA; The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY 10065, USA.
  • Foox J; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY 10021, USA; The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY 10065, USA.
  • El Ghamrasni S; University Health Network, Princess Margaret Cancer Centre, Toronto, ON M5G 1L7, Canada.
  • Mboumba DL; University Paris-Est Créteil, INSERM U955, Institut Mondor de Recherche Biomédicale, 94010 Créteil, France.
  • Duncan GS; University Health Network, Princess Margaret Cancer Centre, Toronto, ON M5G 1L7, Canada.
  • Fortin J; University Health Network, Princess Margaret Cancer Centre, Toronto, ON M5G 1L7, Canada.
  • Sakamoto T; University Health Network, Princess Margaret Cancer Centre, Toronto, ON M5G 1L7, Canada; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
  • Tobin C; University Health Network, Princess Margaret Cancer Centre, Toronto, ON M5G 1L7, Canada.
  • Hodgson K; University Health Network, Princess Margaret Cancer Centre, Toronto, ON M5G 1L7, Canada.
  • Haight J; University Health Network, Princess Margaret Cancer Centre, Toronto, ON M5G 1L7, Canada.
  • Smith LK; University Health Network, Princess Margaret Cancer Centre, Toronto, ON M5G 1L7, Canada.
  • Elia AJ; University Health Network, Princess Margaret Cancer Centre, Toronto, ON M5G 1L7, Canada.
  • Butler D; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY 10021, USA.
  • Berger T; University Health Network, Princess Margaret Cancer Centre, Toronto, ON M5G 1L7, Canada.
  • de Leval L; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital, Lausanne 1011, Switzerland; Lausanne University, Lausanne 1011, Switzerland.
  • Mason CE; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY 10021, USA; The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY 10065, USA; WorldQuant Initiative for Quantitative Prediction, Weill Cornell
  • Melnick A; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY 10065, USA.
  • Gaulard P; University Paris-Est Créteil, INSERM U955, Institut Mondor de Recherche Biomédicale, 94010 Créteil, France; AP-HP, Pathology Department, Henri Mondor Hosital, 94010 Créteil, France.
  • Mak TW; University Health Network, Princess Margaret Cancer Centre, Toronto, ON M5G 1L7, Canada; Departments of Medical Biophysics and Immunology, University of Toronto, Toronto, ON M5G 1L7, Canada; Department of Pathology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong
Cancer Cell ; 41(2): 323-339.e10, 2023 02 13.
Article em En | MEDLINE | ID: mdl-36736318
ABSTRACT
Angioimmunoblastic T cell lymphoma (AITL) is a peripheral T cell lymphoma that originates from T follicular helper (Tfh) cells and exhibits a prominent tumor microenvironment (TME). IDH2 and TET2 mutations co-occur frequently in AITL, but their contribution to tumorigenesis is poorly understood. We developed an AITL mouse model that is driven by Idh2 and Tet2 mutations. Malignant Tfh cells display aberrant transcriptomic and epigenetic programs that impair TCR signaling. Neoplastic Tfh cells bearing combined Idh2 and Tet2 mutations show altered cross-talk with germinal center B cells that promotes B cell clonal expansion while decreasing Fas-FasL interaction and reducing B cell apoptosis. The plasma cell count and angiogenesis are also increased in the Idh2-mutated tumors, implying a major relationship between Idh2 mutation and the characteristic AITL TME. Our mouse model recapitulates several features of human IDH2-mutated AITL and provides a rationale for exploring therapeutic targeting of Tfh-TME cross-talk for AITL patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células T / Dioxigenases / Linfadenopatia Imunoblástica Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células T / Dioxigenases / Linfadenopatia Imunoblástica Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article